Project Number 5R01AG071074-02 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) r. Multi-target Researcher and Organization Principal Investigator BHASIN, SHALENDER Principal Investigator First Name SHALENDER Principal Investigator Last Name BHASIN Awardee Organization BRIGHAM AND WOMEN'S HOSPITAL Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-877: Early Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional) FY Overall Cost $873,053 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official CLARKE, AKANNI YAO
